LEXINGTON, Mass.--(BUSINESS WIRE)--Elpis Biopharmaceuticals, an IND stage biopharmaceutical company developing next generation immunotherapies to transform cancer treatment, today presented two ...
Eden Park Investment Management has partnered with Charles Stanley and SS&C Hubwise to provide a new bespoke on-platform discretionary fund management service. The partnership will see EPIM, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback